Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2025 | 10-2024 | 07-2024 | 04-2024 | 01-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,072 | -5,255 | -4,370 | -2,276 | -1,368 |
| Depreciation Amortization | 3 | 12 | 10 | 7 | 3 |
| Other Working Capital | -149 | -130 | -404 | -354 | -296 |
| Other Operating Activity | -48 | 514 | 983 | -32 | 199 |
| Operating Cash Flow | $-1,265 | $-4,859 | $-3,782 | $-2,655 | $-1,462 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 83 | -272 | 79 | 79 | N/A |
| Other Investing Activity | -14 | 34 | 34 | 0 | 0 |
| Investing Cash Flow | $70 | $-238 | $112 | $79 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 415 | 6,297 | 5,964 | 5,481 | 5,323 |
| Other Financing Activity | -10 | -43 | -33 | -19 | -6 |
| Financing Cash Flow | $405 | $6,254 | $5,931 | $5,462 | $5,317 |
| Exchange Rate Effect | -2 | -12 | -10 | -7 | 4 |
| Beginning Cash Position | 6,574 | 5,428 | 5,428 | 5,428 | 5,428 |
| End Cash Position | 5,781 | 6,574 | 7,680 | 8,306 | 9,286 |
| Net Cash Flow | $-793 | $1,146 | $2,252 | $2,878 | $3,858 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,265 | -4,859 | -3,782 | -2,655 | -1,462 |
| Free Cash Flow | -1,265 | -4,859 | -3,782 | -2,655 | -1,462 |